Applied Biomedical is pleased to announce the appointment of Dean Petkanas as Chief Executive Officer
Dean Petkanas is a corporate finance and executive management professional with over 25 years of investment banking and capital markets experience. In 2010 Mr. Petkanas co-founded Kannalife Sciences, Inc. and for the past 10 years was principally responsible for the creation and execution of the Company’s business model, including the licensing of U.S. Patent #6630507, “Cannabinoids as […]
Dr. Roberto Pietro Antonacci Joins Applied Biomedical as Chief Medical Officer and as member of the Scientific Advisory Board
Lake Grove, NY – October 28th, 2024 – Applied Biomedical, a leading innovator in medical biotechnology, is proud to announce the appointment of Roberto Pietro Antonacci, M.D., as Chief Medical Officer and member of the company’s Scientific Advisory Board. Dr. Antonacci brings a wealth of experience in medical leadership, oncologic and diagnostic imaging knowledge as […]
Applied Biomedical to Present Poster on Rapid Point-of-Care Diagnostics at Respi-DART 2024
October 24, 2024 – Placentia, California – Applied Biomedical (ABM), led by Dr. Subhash Varshney, is pleased to announce the acceptance of its abstract, “Advancing Rapid Point-of-Care Diagnostics and Bacteriophage Therapeutics for Drug-Resistant Bacterial Infections,” for presentation as a poster at Respi-DART 2024. This event, co-hosted by the NIH, will be held in Cabo San […]